These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 24048761)

  • 1. The strain pattern, and not Sokolow-Lyon electrocardiographic voltage criteria, is independently associated with anatomic left ventricular hypertrophy.
    Ehara S; Hasegawa T; Matsumoto K; Otsuka K; Yamazaki T; Iguchi T; Izumi Y; Shimada K; Yoshiyama M
    Heart Vessels; 2014 Sep; 29(5):638-44. PubMed ID: 24048761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical value of apex beat and electrocardiography for the detection of left ventricular hypertrophy from the standpoint of the distance factors from the heart to the chest wall: a multislice CT study.
    Ehara S; Shirai N; Matsumoto K; Okuyama T; Matsumura Y; Yoshikawa J; Yoshiyama M
    Hypertens Res; 2011 Sep; 34(9):1004-10. PubMed ID: 21654756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of obesity on electrocardiographic left ventricular hypertrophy in hypertensive patients : the losartan intervention for endpoint (LIFE) reduction in hypertension study.
    Okin PM; Jern S; Devereux RB; Kjeldsen SE; Dahlöf B;
    Hypertension; 2000 Jan; 35(1 Pt 1):13-8. PubMed ID: 10642268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical value of regression of electrocardiographic left ventricular hypertrophy after aortic valve replacement.
    Yamabe S; Dohi Y; Higashi A; Kinoshita H; Sada Y; Hidaka T; Kurisu S; Shiode N; Kihara Y;
    Heart Vessels; 2016 Sep; 31(9):1497-503. PubMed ID: 26531830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regression of electrocardiographic left ventricular hypertrophy or strain is associated with lower incidence of cardiovascular morbidity and mortality in hypertensive patients independent of blood pressure reduction - A LIFE review.
    Bang CN; Devereux RB; Okin PM
    J Electrocardiol; 2014; 47(5):630-5. PubMed ID: 25052475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ethnic differences in electrocardiographic criteria for left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint.
    Okin PM; Wright JT; Nieminen MS; Jern S; Taylor AL; Phillips R; Papademetriou V; Clark LT; Ofili EO; Randall OS; Oikarinen L; Viitasalo M; Toivonen L; Julius S; Dahlöf B; Devereux RB
    Am J Hypertens; 2002 Aug; 15(8):663-71. PubMed ID: 12160187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cornell product in an electrocardiogram is related to reduced LV regional wall motion.
    Ishikawa J; Yamanaka Y; Watanabe S; Toba A; Harada K
    Hypertens Res; 2019 Apr; 42(4):541-548. PubMed ID: 30542082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of left ventricular hypertrophy by different electrocardiographic criteria in clinical practice. Findings from the Sara study.
    Calderón A; Barrios V; Escobar C; Ferrer E; Barrios S; González-Pedel V; Montoro P; Navarro-Cid J
    Clin Exp Hypertens; 2010 May; 32(3):145-53. PubMed ID: 20504121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrocardiogram Performance in the Diagnosis of Left Ventricular Hypertrophy in Hypertensive Patients With Left Bundle Branch Block.
    Burgos PF; Luna Filho B; Costa FA; Bombig MT; Souza D; Bianco HT; Oliveira Filho JA; Izar MC; Fonseca FA; Póvoa R
    Arq Bras Cardiol; 2017 Jan; 108(1):47-52. PubMed ID: 27992034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Standard electrocardiographic criteria for left ventricular hypertrophy in Nigerian hypertensives.
    Dada A; Adebiyi AA; Aje A; Oladapo OO; Falase AO
    Ethn Dis; 2005; 15(4):578-84. PubMed ID: 16259479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Baseline characteristics in relation to electrocardiographic left ventricular hypertrophy in hypertensive patients: the Losartan intervention for endpoint reduction (LIFE) in hypertension study. The Life Study Investigators.
    Okin PM; Devereux RB; Jern S; Kjeldsen SE; Julius S; Dahlöf B
    Hypertension; 2000 Nov; 36(5):766-73. PubMed ID: 11082141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of electrocardiographic criteria for left ventricular hypertrophy as compared with cardiac computed tomography: from the Rule Out Myocardial Infarction Using Computer Assisted Tomography trial.
    Truong QA; Ptaszek LM; Charipar EM; Taylor C; Fontes JD; Kriegel M; Irlbeck T; Toepker M; Schlett CL; Bamberg F; Blankstein R; Brady TJ; Nagurney JT; Hoffmann U
    J Hypertens; 2010 Sep; 28(9):1959-67. PubMed ID: 20498615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ECG left ventricular hypertrophy as a risk predictor of sudden cardiac death.
    Porthan K; Kenttä T; Niiranen TJ; Nieminen MS; Oikarinen L; Viitasalo M; Hernesniemi J; Jula AM; Salomaa V; Huikuri HV; Albert CM; Tikkanen JT
    Int J Cardiol; 2019 Feb; 276():125-129. PubMed ID: 30293667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct role of electrocardiographic criteria in echocardiographic diagnosis of left ventricular hypertrophy according to age, in the general population: the Ikaria Study.
    Tsiachris D; Chrysohoou C; Oikonomou E; Lazaros G; Dimitriadis K; Maragiannis D; Roussos D; Andreou I; Tsantilas A; Christoforatou E; Pitsavos C; Panagiotakos D; Stefanadis C
    J Hypertens; 2011 Aug; 29(8):1624-32. PubMed ID: 21610511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gender differences in factors influencing electrocardiographic findings of left ventricular hypertrophy in severe aortic stenosis.
    Satoh S; Omura S; Inoue H; Ejima E; Shimozono K; Hayashi M; Mori T; Takenaka K; Kawamura N; Numaguchi K; Mori E; Asoh A; Nakamura T; Hiyamuta K
    Heart Vessels; 2014 Sep; 29(5):659-66. PubMed ID: 23979264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of left ventricular hypertrophy by the R-wave voltage in lead aVL: population-based study.
    Rodrigues SL; Angelo LC; Baldo MP; Dantas EM; Barcelos AM; Pereira AC; Krieger JE; Mill JG
    Clin Res Cardiol; 2013 Sep; 102(9):653-9. PubMed ID: 23660930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants and prognostic significance of electrocardiographic left ventricular hypertrophy criteria in chronic kidney disease.
    Agarwal R; Light RP
    Clin J Am Soc Nephrol; 2011 Mar; 6(3):528-36. PubMed ID: 21088286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events.
    Okin PM; Devereux RB; Jern S; Kjeldsen SE; Julius S; Nieminen MS; Snapinn S; Harris KE; Aurup P; Edelman JM; Wedel H; Lindholm LH; Dahlöf B;
    JAMA; 2004 Nov; 292(19):2343-9. PubMed ID: 15547161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of obesity on the diagnostic value of electrocardiographic criteria for detecting left ventricular hypertrophy.
    Abergel E; Tase M; Menard J; Chatellier G
    Am J Cardiol; 1996 Apr; 77(9):739-44. PubMed ID: 8651126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic performance of electrocardiographic criteria in echocardiographic diagnosis of different patterns of left ventricular hypertrophy.
    Oikonomou E; Theofilis P; Mpahara A; Lazaros G; Niarchou P; Vogiatzi G; Tsalamandris S; Fountoulakis P; Christoforatou E; Mystakidou V; Anastasiou M; Goliopoulou A; Tousoulis D
    Ann Noninvasive Electrocardiol; 2020 May; 25(3):e12728. PubMed ID: 31724804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.